|
|
 |
 |
 |
 |
 |
 |
|
|
Yichen Lu
 Dr. Yichen Lu is the Principal Research Scientist for HAI and the Harvard School of Public Health’s Department of Immunology and Infectious Diseases. Dr. Lu heads HAI’s China Initiative and serves as the Executive Director of HAI for International Vaccine Development, Inc., a non-profit organization that promotes vaccine research and development in developing countries, and as Special Professor and Director of the Nankai University Vaccine Laboratory in Tianjin, China.
The focus of much of the research in Dr. Lu's laboratory is vaccine research and development, particularly T-cell vaccines. Additionally, he has worked extensively on simian/human immunodeficiency virus (SHIV) as well as HIV, an approach that allows for general primate retrovirus research.
One of Dr. Lu's major findings involves a model for anthrax-based vaccine design. In collaboration with the Walter Reed Army Institute of Research, Dr. Lu’s group plans to test the new candidate AIDS vaccine in human studies in the US.
Dr. Lu holds a number of patents for his research findings, and served on the Presidential Advisory Council on HIV/AIDS’ AIDS Vaccine Expert Panel in 1997. He holds a Ph.D. from Temple University in Philadelphia, Pennsylvania.
|
|
|
